Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy

Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy

Background/Aim. Introducing tyrosine kinase inhibitors (TKIs) has essentially changed curative approach, to be precise, clearly improved treatment efficacy for chronic myeloid leukemia (CML). Thus, the place and usage of allogeneic stem cell transplant (SCT) in CML treatment - as a former "n...

Full description

Bibliographic Details
Main Authors: Stamatović Dragana, Balint Bela, Tukić Ljiljana, Elez Marija, Tarabar Olivera, Todorović Milena, Todorić-Živanović Biljana, Ostojić Gordana, Tatomirović Željka, Marjanović Slobodan, Malešević Milomir
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2012-01-01
Series:Vojnosanitetski Pregled
Subjects:
leukemia, myelogenous chronic bcr-abl positive
stemcells
transplantation homologous
treatment outcome
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2012/0042-84501201037S.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2012/0042-84501201037S.pdf

Similar Items